Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1996 1
2004 1
2006 1
2007 1
2008 2
2010 2
2011 1
2012 2
2013 3
2014 1
2016 2
2017 2
2018 2
2020 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Updates on the Treatment of Tenosynovial Giant Cell Tumor.
Chan AS, Katiyar V, Dy P, Singh V. Chan AS, et al. Among authors: dy p. Hematol Oncol Stem Cell Ther. 2023 May 23;16(4):307-315. doi: 10.56875/2589-0646.1032. Hematol Oncol Stem Cell Ther. 2023. PMID: 37363972 Review.
Autoimmune Hemolytic Anemia as Presenting Symptom of Hodgkin Lymphoma.
Burley NB, Dy PS, Hande S, Kalantri S, Mohindroo C, Miller K. Burley NB, et al. Among authors: dy ps. Case Rep Hematol. 2021 Mar 31;2021:5580823. doi: 10.1155/2021/5580823. eCollection 2021. Case Rep Hematol. 2021. PMID: 33859850 Free PMC article.
A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor-positive Breast Cancer, SWOG S1222.
Moore HCF, Barlow WE, Somlo G, Gralow JR, Schott AF, Hayes DF, Kuhn P, Hicks JB, Welter L, Dy PA, Yeon CH, Conlin AK, Balcueva E, Lew DL, Tripathy D, Pusztai L, Hortobagyi GN. Moore HCF, et al. Among authors: dy pa. Clin Cancer Res. 2022 Feb 15;28(4):611-617. doi: 10.1158/1078-0432.CCR-21-3131. Clin Cancer Res. 2022. PMID: 34844978 Free PMC article. Clinical Trial.
A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408.
Evens AM, Hong F, Habermann TM, Advani RH, Gascoyne RD, Witzig TE, Quon A, Ranheim EA, Ansell SM, Cheema PS, Dy PA, O'Brien TE, Winter JN, Cescon TP, Chang JE, Kahl BS. Evens AM, et al. Among authors: dy pa. Clin Cancer Res. 2020 Sep 1;26(17):4468-4477. doi: 10.1158/1078-0432.CCR-20-1345. Epub 2020 Jun 12. Clin Cancer Res. 2020. PMID: 32532790 Free PMC article. Clinical Trial.
26 results